Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Lipitor, Apo-Atorvastatin, Atorsave F (Show all)
Atorvastatin is an antilipemic agent used for the treatment of lipid disorders, including hyperlipidemia or primary prevention of atherosclerotic cardiovascular disease.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| High Cholesterol | 231 | 48 |
|
|
|
|
|
| Other | 62 | 6 |
|
|
|
||
| Hypercholesterolemia | 45 | 7 |
|
|
|
||
| General health | 41 | 6 |
|
|
|
||
| Hyperlipidemia | 15 | 1 |
|
||||
| Increased lipids in blood (hyperlipidemia) | 15 | 4 |
|
|
|
See all 427 patients currently taking Atorvastatin
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Atorvastatin
| Joints ache | 6 | |
|---|---|---|
| Muscle aches | 6 | |
| Muscle soreness | 6 | |
| Joint tenderness | 6 | |
| Generalized weakness (asthenia) | 1 | |
| Nausea | 1 | |
| See all 29 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Atorvastatin. See all 18 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 35 | ||
| Side effects too severe | 30 | ||
| Other | 17 | ||
| Expense | 15 | ||
| Did not seem to work | 10 | ||
| Personal research | 10 | ||
| Change in health plan coverage | 7 | ||
| Course of treatment ended | 5 | ||
| Not indicated | 3 |
Adherence
Taking treatment as prescribed
Adherence of Atorvastatin
Always |
59 | 78% |
|
|---|---|---|---|
Usually |
10 | 13% |
|
Sometimes |
1 | 1% |
|
Never |
6 | 8% |
|
Burden
Difficulty being on treatment
Burden of Atorvastatin
Very |
2 | 3% |
|
|---|---|---|---|
Somewhat |
2 | 3% |
|
A little |
10 | 13% |
|
Not at all |
62 | 82% |
|
Cost
Paid out of pocket
Cost of Atorvastatin
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
3 | 5% |
|
$50-99 |
4 | 7% |
|
$25-49 |
13 | 24% |
|
< $25 |
34 | 62% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 11, 2012.